Med. Review Video Module: What is the efficacy of ixekizumab across the GRAPPA & EULAR domains?

RhAPPcast

Join Jessica Farrell, PharmD, a clinical pharmacist and board member of RhAPP, as she breaks down the efficacy of ixekizumab across the GRAPPA domains. In this video, she covers the impact of ixekizumab on peripheral arthritis, axial disease, enthesitis, dactylitis, skin, and nail psoriasis, based on the latest clinical trial data. Learn how this treatment can significantly improve various symptoms in patients with psoriatic arthritis.

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes, and get the latest updates.

Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada